Literature DB >> 639053

Potentiation of concanavalin A-bound L1210 vaccine in vivo by chemotherapeutic agents.

T Kataoka, H Kobayashi, Y Sakurai.   

Abstract

Mesh:

Substances:

Year:  1978        PMID: 639053

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  7 in total

1.  Augmented induction of antitumor cells in vivo by cyclophosphamide fails to benefit antitumor resistance of the host.

Authors:  K Ryoyama; C Ryoyama
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

2.  Combination chemoimmunotherapy for advanced gastric carcinoma.

Authors:  T Akiyoshi; M Kawaguchi; S Arinaga; S Miyazaki; F Koba; T Wada; H Tsuji
Journal:  Jpn J Surg       Date:  1984-05

3.  A trial of postoperative adjuvant combination chemo-immunotherapy for stage IV gastric carcinoma.

Authors:  T Akiyoshi; S Arinaga; K Takamuku; T Wada; F Koba; H Tsuji
Journal:  Jpn J Surg       Date:  1988-09

4.  Non-cytotoxic activity of pyran copolymer-induced macrophages associated with potentiation of tumour vaccine in recipient mice.

Authors:  T Kataoka; F Oh-hashi
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

5.  Characteristics of DTH suppressor cells in mice infected with Candida albicans.

Authors:  J C Valdez; O E Mesón; A Sirena; N G de Alderete
Journal:  Mycopathologia       Date:  1987-05       Impact factor: 2.574

6.  Tumour immunoprophylaxis in mice using glutaraldehyde-treated syngeneic myeloma cells.

Authors:  S Ben-Efraim; R Ophir; E H Relyveld
Journal:  Br J Cancer       Date:  1981-04       Impact factor: 7.640

7.  Successful immunotherapy with micrococcus, BCG or related polysaccharides on L1210 leukaemia after BCNU chemotherapy.

Authors:  R Verloes; G Atassi; P Dumont; L Kanarek
Journal:  Br J Cancer       Date:  1981-02       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.